MabVax Therapeutics Holdings Inc. (fka MBVXQ)

[Rogerthat1]

In connection with the listing of our shares of common stock on The NASDAQ Capital Market, we intend to implement a 1 for 7.4 reverse split of our issued and outstanding common stock on the date that we price this offering. All per share amounts in this prospectus (other than in our financial statements and the notes thereto) have been retroactively restated to reflect the reverse stock split.